Bharti Airtel, Wipro, Jubilant Foodworks and other top stocks to watch out for on July 22

Jul 22, 2021

By: Rounak Jain

Bharti Airtel

The Supreme Court will give its verdict on the plea for re-computation of AGR dues. Bharti Airtel owes over ₹43,000 crore, while Vodafone Idea owes over ₹50,000 crore, according to the Department of Telecom.

Credit: BCCL

...contd

Bharti Airtel has announced a collaboration with Intel for its 5G network development.

Credit: Bharti-Airtel

Wipro

Announced that it will invest $1 billion (approx. ₹7,400 crore) over the next three years in cloud technologies, acquisitions and partnerships.

Credit: Wipro

Jubilant FoodWorks

The Domino’s operator reported a net profit of ₹69 crore after reporting a loss of ₹74 crore a year ago, since the lockdowns had a major impact last year. Revenue surged by 130 percent to touch ₹893 crore.

Credit: Unsplash

Earnings today

Hindustan Unilever, Bajaj Auto, Hindustan Zinc, Ultratech Cement, Biocon, Mphasis, Indian Energy Exchange, IndiaMart InterMesh, Sterlite Technologies, Wockhardt, Bank of Maharashtra, IIFL Securities, Agro Tech Foods, India Pesticides, South Indian Bank, among others.

Credit: Pixabay

Adani Ports & SEZ

To issue US dollar denominated senior notes as it looks to repay existing debts and raise funds for capital expenditure.

Credit: Adani-Ports-SEZ

Infosys

Its US subsidiary has launched a blockchain network to modernise public recordkeeping for the County of Riverside in California.

Credit: Infosys

Bajaj Finserv

Its net profit in the June 2021 quarter is down by 15 percent to ₹833 crore when compared to the previous quarter. Revenue is down by 9 percent at ₹13,949 crore, quarter-on-quarter.

Credit: Bajaj-Finserv

IPO Watch

Tatva Chintan Pharma Chem IPO subscribed by over 180 times at the end of Day 3. Glenmark Life Sciences has filed a DRHP for a ₹1,060 crore IPO.

Credit: Flickr

Gland Pharma

Reported a 12 percent rise in net profit to ₹351 crore in the June 2021 quarter compared to a year ago. Revenue surged by 31 percent to ₹1,154 crore in the same period.

Credit: Gland-Pharma

After selling their previous startup to Quikr, Zefo founders are building an OYO for hospitals